Jun Wei
Impact in
-
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Immunotherapy and Biomarkers
-
- Head and Neck Cancer Studies
Papers in
-
- Prostate Cancer Diagnosis and Treatment 2
- Prostate Cancer Treatment and Research 2
- Gastric Cancer Management and Outcomes 2
- Ferroptosis and cancer prognosis 1
- Oncology 7
- Co-authors
- Bikui Tang (1 shared paper)Yongjie Zhao (1 shared paper)Yingjie Shao (2 shared papers)Biao Yang (1 shared paper)Zhonghua Ning (2 shared papers)Jun Xi (1 shared paper)Jin Huang (2 shared papers)Zhuqing Shi (11 shared papers)
- Journals
- The Prostate (3 papers)Urologic Oncology Seminars and Original Investigations (1 paper)Atherosclerosis Supplements (1 paper)Frontiers in Cardiovascular Medicine (1 paper)Cancer Medicine (1 paper)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Jun Wei
23 papers receiving 266 citations
Peers
Comparison fields: 5 of 58
- Oncology 71
- Otorhinolaryngology 11
- Pulmonary and Respiratory Medicine 54
- Cancer Research 23
- Infectious Diseases 27
Countries citing papers authored by Jun Wei
This map shows the geographic impact of Jun Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Wei more than expected).
Fields of papers citing papers by Jun Wei
This network shows the impact of papers produced by Jun Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Wei. The network helps show where Jun Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 47 | |
| 2 | 2020 | 41 | |
| 3 | 2020 | 36 | |
| 4 | 2014 | 21 | |
| 5 | BLT2 is a pro-tumorigenic mediator during cancer progression and a therapeutic target for anti-cancer drug development. | 2013 | 19 |
| 6 | 2020 | 16 | |
| 7 | 2011 | 13 | |
| 8 | 2019 | 13 | |
| 9 | 2021 | 9 | |
| 10 | Application of intravoxel incoherent motion diffusion-weighted imaging in differential diagnosis and molecular subtype analysis of breast cancer. | 2021 | 9 |
| 11 | 2019 | 8 | |
| 12 | Clinicopathological features and prognosis of gastric mixed adenoneuroendocrine carcinoma. | 2018 | 7 |
| 13 | 2006 | 7 | |
| 14 | 2018 | 5 | |
| 15 | 2021 | 4 | |
| 16 | 2024 | 3 | |
| 17 | 2025 | 2 | |
| 18 | 2025 | 2 | |
| 19 | 2025 | 2 | |
| 20 | 2025 | 1 |
About Jun Wei
Jun Wei is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Surgery and Genetics, having authored 27 papers that have together received 268 indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (2 papers), Prostate Cancer Treatment and Research (2 papers), Gastric Cancer Management and Outcomes (2 papers), Cancer-related molecular mechanisms research (2 papers), Click Chemistry and Applications (1 paper), DNA Repair Mechanisms (1 paper), Cancer Genomics and Diagnostics (1 paper) and Ferroptosis and cancer prognosis (1 paper). The work is most often cited by research in Oncology (71 citations), Otorhinolaryngology (11 citations), Pulmonary and Respiratory Medicine (54 citations), Cancer Research (23 citations) and Infectious Diseases (27 citations). Jun Wei has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Bikui Tang, Yongjie Zhao, Yingjie Shao, Biao Yang, Zhonghua Ning, Jun Xi, Jin Huang, Zhuqing Shi, Brian T. Helfand and William B. Isaacs. Their work appears in journals such as The Prostate, Urologic Oncology Seminars and Original Investigations, Atherosclerosis Supplements, Frontiers in Cardiovascular Medicine and Cancer Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.